Treatment of intra-abdominal infections using imipenem/cilastatin
Leaper, D.; Thomas, W.; Kennedy, R.; Leow, C.; Avery, D.
Chemioterapia International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 467-468
1987
ISSN/ISBN: 0392-906X PMID: 3334603 Document Number: 286368
Document emailed within 1 workday
Related Documents
Mao, P.; Enrichens, F.; Olivero, G.; Sciascia, C.; Benedetto, G.; Franchello, A.; Olivero, S. 1991: Imipenem-cilastatin in the treatment of hospital infections Journal of ChemoTherapy 3(Suppl 1): 205-207Doko, F. 1986: Imipenem/cilastatin sodium in the treatment of obstetric and gynecologic infections Japanese Journal of Antibiotics 39(5): 1427-1431
Fujii, R.; Sakata, H.; Inyaku, F.; Fujita, K.; Maruyama, S.; Yoshioka, H.; Hashira, S.; Tajima, T.; Nakazawa, S.; Sato, H. 1989: Pharmacokinetic and clinical evaluation of imipenem/cilastatin sodium in neonates and premature infants. A study of imipenem/cilastatin sodium by a perinatal co-research group Japanese Journal of Antibiotics 42(4): 953-972
Hou, F.; Li, J.; Wu, G.; Zheng, B.; Chen, Y.; Gu, J.; Wang, H.; Huo, L.; Xue, X.; Jia, C.; Yin, Y.; Tian, X.; Ren, S. 2002: A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections Chinese Medical Journal 115(12): 1849-1854
Poenaru, D.; De Santis, M.; Christou, N.V. 1990: Imipenem versus tobramycin--antianaerobe antibiotic therapy in intra-abdominal infections Canadian Journal of Surgery. Journal Canadien de Chirurgie 33(5): 415-422
Oizumi, K.; Rikimaru, T.; Shiraishi, T.; Motohiro, A.; Yoshida, M.; Watanabe, K.; Maruyama, R.; Ishibashi, T.; Kitahara, Y.; Kido, M.; Yoshii, C.; Hara, N.; Ikeda, A.; Yamada, H.; Ninomiya, K.; Matsuzaki, Y.; Ichinose, Y.; Namba, K.; Kodama, T.; Kunitake, R.; Miyazaki, N.; Abe, K.; Matsunaga, R.; Ide, H.; Kamae, I. 1999: Imipenem/cilastatin sodium and other beta-lactams for respiratory tract infections: clinical benefit and treatment days for cure Japanese Journal of Antibiotics 52(1): 1-15
Oizumi, K.; Rikimaru, T.; Shiraishi, T.; Motohiro, A.; Yoshida, M.; Watanabe, K.; Maruyama, R.; Ishibashi, T.; Kitahara, Y.; Kido, M.; Yoshii, C.; Hara, N.; Ikeda, A.; Yamada, H.; Ninomiya, K.; Matsuzaki, Y.; Ichinose, Y.; Namba, K.; Kodama, T.; Kunitake, R.; Miyazaki, N.; Abe, K.; Matsunaga, R.; Ide, H.; Kamae, I. 1999: Imipenem/cilastatin sodium and other beta-lactams for respiratory tract infections: clinical benefit and treatment days for cure Japanese Journal of Antibiotics 52(1): 1-15
Konaga, E.; Takeuchi, H.; Orita, K.; Fuchimoto, S.; Ogawa, K.; Kitagawa, T.; Tokuda, N.; Kimura, H.; Hamada, F.; Nishiyama, Y. 1991: Clinical evaluation of intramuscular imipenem/cilastatin sodium in surgical infections Japanese Journal of Antibiotics 44(12): 1341-1350
Takamoto, M.; Ishibashi, T.; Toyoshima, H.; Tanaka, H.; Tamaru, N.; Watanabe, K.; Yoshida, M.; Tokunaga, N.; Ichikawa, Y.; Oizumi, K. 1994: Imipenem/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections Japanese Journal of Antibiotics 47(9): 1131-1144
Piyasirisilp, S.; Premprawat, W.; Thamlikitkul, V. 2010: Therapeutic equivalence of generic imipenem/cilastatin for therapy of infections at Siriraj Hospital Journal of the Medical Association of Thailand 93(Suppl 1): S117-S125
Shindo, K.; Hori, T.; Hayashi, M.; Kiyokawa, S.; Maeda, K.; Iwasaki, S.; Maruta, N.; Yamada, J.; Morimitsu, H.; Taide, M.; Hoshino, K.; Shimomae, H.; Matsuo, R.; Suzu, H.; Nishimura, N.; Hashiguchi, J.; Saito, Y. 1997: Efficacy and safety of intramuscular imipenem/cilastatin (IPM/CS) for complicated urinary tract infections Japanese Journal of Antibiotics 50(7): 628-639
Fassas, A.; Papageorgiou, T.; Kontodimou, A.; Proya, E.; Hadjikyrkou, M.; Anagnostopoulos, A. 1989: Imipenem/cilastatin as initial single-agent therapy for infections in cancer patients with neutropenia Journal of ChemoTherapy 1(4 Suppl): 1295-1297
Cristiano, P. 1989: Clinical evaluation of imipenem/cilastatin in the therapy of severe infections in high-risk patients Drugs under Experimental and Clinical Research 15(1): 17-20
Mikasa, K.; Sawaki, M.; Konishi, M.; Narita, N. 1990: Clinical efficacy of imipenem/cilastatin sodium in patients with respiratory tract infections caused by Pseudomonas aeruginosa Japanese Journal of Antibiotics 43(1): 9-13
Sze, E.H.; Osborne, N.G.; Adelson, M.D.; Granato, P. 1988: Emergence of imipenem-resistant Pseudomonas aeruginosa during treatment of intra-abdominal infection in a patient with ovarian carcinoma Journal of the National Medical Association 80(10): 1133-1135
Kuo, B.I.; Fung, C.P.; Liu, C.Y. 2000: Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients Zhonghua Yi Xue Za Zhi 63(5): 361-367
Oomomo, Y.; Maruhashi, T.; Hanaoka, J.; Minagawa, Y.; Yuzawa, H.; Tokunaga, A.; Takahashi, T.; Sasagawa, S.; Takeuchi, S. 1986: Clinical studies on the effect of imipenem/cilastatin sodium on infections in obstetrics and gynecology. Tissue concentrations and clinical effects Japanese Journal of Antibiotics 39(5): 1342-1349
Janvier, G.; Carles, J. 1993: Efficacy and tolerance of imipenem/cilastatin in the adjuvant treatment of surgery for peritonitis in patients over the age of 70 years Annales de Chirurgie 47(4): 370-375
Levy, E.; Levy, P. 1993: Contribution of imipenem/cilastatin in the treatment of peritonitis: a comparative economic analysis in the case of France Journal de Chirurgie 130(4): 200-209
Cainzos Fernández, M. 1997: Meropenem in the treatment of surgical intra-abdominal infections Enfermedades Infecciosas y Microbiologia Clinica 15(Suppl 1): 51-56